A multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma patients at high risk of recurrence-MedSci.cn

A multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma patients at high risk of recurrence

Slingluff, C; Blumenstein, B; Lewis, K; Andtbacka, R; Hyngstrom, J; Milhem, M; Markovic, S; Hamid, O; Hernandez-Aya, L; Bowles, T; Philips, P; Claveau, J; Jang, S; Lutzky, J; Bar, A; Beitsch, P

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019; 7 ():

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

A multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma patients at high risk of recurrence

科室

工具

服务